A new era for hepatitis C-new diagnostics tools and new weapons

ACS Medicinal Chemistry Letters

Volumn 3, Issue 6, 2012, Pages 440-441

  Soriano, Vicente ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 333; ABT 450; ANTIVIRUS AGENT; ASUNAPREVIR; BI 1335; BI 7127; BOCEPREVIR; DACLATASVIR; DANOPREVIR; GS 7977; GS 9256; IDX 184; MERICITABINE; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA PLUS RIBAVIRIN; RIBAVIRIN; SIMEPREVIR; TELAPREVIR; UNCLASSIFIED DRUG;

DIAGNOSTIC PROCEDURE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; VIRAL GENETICS;

EID: 84862275679     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300098k     Document Type: Note

References (3)

1. Ly, K. N.; Xing, J.; Klevens, R. M.; Jiles, R.B.; Ward, J. W.; Holmberg, S. D. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 Ann. Intern. Med. 2012, 156, 271-278
2. Ge, D.; Fellay, J.; Thompson, A. J.; Simon, J. S.; Shianna, K. V.; Urban, T. J.; Heinzen, E. L.; Qiu, P.; Bertelsen, A. H.; Muir, A. J.; Sulkowski, M.; McHutchison, J. G.; Goldstein, D. B. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 2009, 461, 399-401
3. Reitz, A. B. Future Horizons in Drug Discovery Research ACS Med. Chem. Lett. 2012, 3, 80-82